NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 981 filers reported holding NOVARTIS A G in Q2 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,532,000 | -12.9% | 18,587 | +0.0% | 0.38% | +24.8% |
| Q4 2019 | $1,759,000 | +9.0% | 18,579 | 0.0% | 0.31% | -4.4% |
| Q3 2019 | $1,614,000 | -6.4% | 18,579 | -1.6% | 0.32% | -13.0% |
| Q2 2019 | $1,725,000 | -4.4% | 18,887 | +0.6% | 0.37% | -8.9% |
| Q1 2019 | $1,805,000 | +12.1% | 18,772 | +0.0% | 0.40% | +18.5% |
| Q4 2018 | $1,610,000 | -0.7% | 18,766 | -0.3% | 0.34% | -28.1% |
| Q3 2018 | $1,622,000 | +14.4% | 18,822 | +0.3% | 0.47% | +5.3% |
| Q2 2018 | $1,418,000 | -99.9% | 18,766 | -0.1% | 0.45% | -32.1% |
| Q1 2018 | $1,571,515,000 | +102079.1% | 18,791 | +2.6% | 0.66% | +48.3% |
| Q4 2017 | $1,538,000 | -2.2% | 18,320 | 0.0% | 0.45% | +12.0% |
| Q3 2017 | $1,573,000 | +2.9% | 18,320 | 0.0% | 0.40% | -13.4% |
| Q2 2017 | $1,529,000 | +9.6% | 18,320 | +1.1% | 0.46% | +14.4% |
| Q1 2017 | $1,395,000 | +3.9% | 18,117 | -1.7% | 0.40% | 0.0% |
| Q4 2016 | $1,343,000 | – | 18,437 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |